Skip to main content

Insights in Infectious Agents and Disease: 2023/2024

Cover image for Research Topic "Insights in Infectious Agents and Disease: 2023/2024"
317kviews
Editorial16 October 2025
Editorial: Insights in infectious agents and disease: 2023/2024

Editorial on the Research Topic Insights in Infectious Agents and Disease: 2023/2024 This third edition of the Research Topic Insights in Infectious Agents and Disease, gathered 34 published articles, and provided as in previous editions an overview of recent developments in the field of bacterial, viral, and parasitic infectious diseases. Most publications (n=23) concerned bacterial infectious agents and diseases as in the previous editions. 1. Bacterial diseases Of note for this edition, 10 Review or Systematic Review articles were published. Regarding bacterial pathogenesis, Chakkour et al. provided an overview of Proteus mirabilis pathogenicity and virulence with a particular focus on the role of metals, siderophores, iron metal chelating and transporting metallophores, displaying a potential target for therapeutic intervention. Petakh et al. explored the complex interplay between gut microbiome, stress, and leptospirosis, a re-emerging zoonotic disease of significant global health concern. In addition, Petakh et al., in a mini-review, reported also the current treatment options for leptospirosis. Among them, the authors discussed novel treatment options, such as bacteriophages and newly synthesized/natural compounds. Jin reviewed the role of bacterial virulence factors and host elements involved in septic arthritis, together with insights provided from animal models of infection to develop novel therapeutic strategies against this infectious disease. In another Review Article, Li et al. raised an important question regarding the oral-brain axis, in particular if periodontal pathogens can trigger the onset and progression of Alzheimer's disease. In the field of prophylaxis and therapy, Zafar et al. provided an overview of current and emerging approaches for eliminating Borrelia burgdorferi responsible for Lyme disease, including currently employed antimicrobial treatment approaches and vaccine candidates. Maurin et al. reviewed non-vaccinal prophylaxis of tularemia, caused by the intracellular pathogen and biological threat agent Francisella tularensis. No vaccine is currently available for humans or animals. The authors discuss the currently underdeveloped possibilities for collective prophylaxis which would require a One Health approach to control animal and environmental reservoirs, including the arthropod vectors, to slow current expansion of this disease in a context of climate change. Zahid et al. provided an overview on recent advances in otitis media vaccine developments and animal model systems. Several bacterial pathogens may be involved in otitis media, and therefore the development of multi-species vaccines is required to reduce the global burden of this disease. More largely in the field of vaccine development, Fantoni et al. reviewed the current challenges and improvements in assessing the immunogenicity of bacterial vaccines. In the field of bacterial infection diagnosis, Dixit et al., discussed using a systematic review and meta-analysis approach, the diagnostic accuracy of point-of-care nucleic acid-based isothermal amplification assays for scrub typhus, caused by bacterial pathogens of the genera Rickettsia and Orientia. The remaining bacterial infectious diseases-related publications were Original Research articles and concerned mostly genomic studies on specific bacterial pathogens. Ghielmetti et al. presented a new approach for animal tuberculosis surveillance using culture-independent long-read whole-genome sequencing. Related to this study, using culture-independent deep sequencing of DNA, Cooke et al. identified Mycobacterium bovis in nasal swabs from communal goats (Capra hircus) in rural KwaZula-Natal, South Africa. Regarding wildlife animal tuberculosis, Alba et al. provided genomic insights into a Mycobacterium pinnipedii isolate causing tuberculosis in a captive South American sea lion (Otaria flavescens) from Italy. Regarding human tuberculosis, Marcon et al., using a comprehensive genomic surveillance approach, identified transmission profiles of extensively drug-resistant Mycobacterium tuberculosis cases in Brazil. Several Original Research publications dealt with enteric pathogens. Kalalah et al. studied the pathogenomes and virulence profiles of representative big six non-O157 serogroup Siga toxin-producing Escherichia coli. Zuo et al. provided comparative genomic and antimicrobial resistance profiles of Salmonella strains isolated from pork and human sources in Sichuan, China, highlighting the role of pork as a reservoir and transmission source for certain Salmonella sequence types. For another important genus/species belonging to the Enterobacterales family, Arcari et al. developed a Providencia stuartii multilocus sequence typing scheme, useful for subspecies classification and identification. To assess gastrointestinal colonization in experimental models of infection, Wan et al. investigated gut microbiome changes in mouse, Mongolian gerbil, and hamsters following a challenge with another important enteric pathogen, namely Clostridioides difficile. In the field of control of enteric pathogens, Shaw et al. studied the interplay between Salmonella enterica Typhimurium and the probiotic Bifidobacterium infantis during co-infection. Of importance are also hospital-acquired infections, and Bello-López et al. reported on the emergence of Acinetobacter pittii carrying diverse antibiotic resistance genes, which may be responsible for the emergence of this pathogen, together with the high antibiotic selective pressure exerted in the hospital setting. Regarding zoonotic diseases, Qiu et al. assessed microbiota in organs of the horseflies, constituting an important vector for pathogen transmission, in Northeastern China, and identified an important group of zoonotic pathogens such as Brucella. For another important vector borne and more precisely tick-borne disease, Alruwaili et al. reported superior efficacy of combination antibiotic therapy versus monotherapy in a mouse model of Lyme disease. More mechanistically in the field of microbial pathogenesis, Chen et al. provided evidence for the role of Mycoplasma genitalium adhesion protein in inhibition of human urethral epithelial cells apoptosis via CypA/P13K/AKT/m-TOR-dependent authophagy. 2. Viral diseases One Review article and six Original Research articles concerned human viral infectious diseases of primary importance such as COVID-19 or AIDS. Gurrola et al. provided a review on delivering CRISPR to the HIV-1 reservoirs, as a curative strategy for the inactivation and/or elimination of integrated proviral DNA within host cells. Anderson et al. investigated persistence and risk factors of occult hepatitis B virus infections among antiretroviral therapy-naïve people living with HIV in Botswana. Regarding COVID-19, da Silva et al. presented a study on genomic surveillance and serological profile of SARS-CoV-2 variants circulating in Macaé and nearby cities, southeastern Brazil. In another study of epidemiological importance, Romano et al. provided phylogenetic and epidemiological insights into centenarians' resilience to COVID-19 by exploring the role of past coronavirus pandemics, from the 19th till 21st century. In the field of therapy, El Khoury and Naim presented experimental evidence that lipid rafts disruption by statins negatively impacts the interaction between SARS-CoV-2 S1 subunit and ACE2 in intestinal epithelial cells, representing a promising therapeutic intervention to treat this viral infection. As another therapeutic approach, Abutbul et al. reported Tumor Treating Fields (TTFields) demonstrate antiviral functions in vitro, and safety for application to COVID-19 patients in a pilot clinical study. For another important viral disease, Ren et al. investigated reactivation of cytomegalovirus and bloodstream infection and its impact on early survival after allogeneic haematopoietic stem cell transplantation. 3. Fungal diseases Two Original Research studies concerned fungal pathogens. Xu et al. reported the clinical isolation, biofilm formation, and pathogenicity analysis of three species of the Stephanoascus ciferii complex, namely Stephanoascus ciferrii, Candida allociferrii, and Candida mucifera. In the field of host-pathogen interaction, Porollo et al. investigated regulatory mechanisms involved in copper sensing and tolerance in Pneumocystis species. These fungal pathogens replicate extracellularly in lung alveoli and thrive in the copper-enriched environment of mammalian lungs, hence the importance of studying copper interactions with these pathogenic species. 4. Multiple pathogen diseases Infectious pathology states can also involve diverse multiple pathogenic species at the site of infection, and may be difficult to treat because of their multiple infectious etiology. Fabrizio et al. investigated the efficacy of sodium hypochlorite in overcoming antimicrobial resistance and eradicating biofilms in clinical pathogens from pressure ulcers (PU). The PU isolates analyzed comprised multiple drug resistant bacteria of the ESKAPE group along with fungal Candida albicans isolates. Regarding viral and bacterial co-infections, Maboni et al. provided new insights into the feline respiratory disease complex (FRDC), a highly prevalent syndrome in cats that often result in fatal outcomes. The authors detected a wide range of pathogens involved in this syndrome, of which the most detected were Mycoplasma, feline calicivirus (FCV), and felid alphaherpesvirus 1 (FeHV-1). Co-infections of Mycoplasma and FCV or Mycoplasma and FeHV-1 were found to be important predictors of disease severity.

2,549 views

ORIGINAL RESEARCH
26 March 2025
Mycoplasma genitalium protein of adhesion inhibits human urethral epithelial cells apoptosis via CypA/PI3K/AKT/mTOR-dependent autophagy
Li Chen, 7 more and Yanhua Zeng

3,285 views

7 citations

ORIGINAL RESEARCH
22 January 2025
Comprehensive genomic surveillance reveals transmission profiles of extensively drug-resistant tuberculosis cases in Pará, Brazil
Davi Josué Marcon, 13 more and Emilyn Costa Conceição

5,588 views

6 citations

ORIGINAL RESEARCH
31 October 2024
Development of a Providencia stuartii multilocus sequence typing scheme
Gabriele Arcari, 3 more and Valerio Capitani

3,659 views

8 citations

ORIGINAL RESEARCH
3 March 2025
Comparative genomic and antimicrobial resistance profiles of Salmonella strains isolated from pork and human sources in Sichuan, China
Haojiang Zuo, 15 more and Lvbo Tian

3,800 views

5 citations

Current and emerging approaches for eliminating Borrelia burgdorferi and alleviating persistent Lyme disease symptoms
Lyme disease is the most prevalent tick-borne infection caused by Borrelia burgdorferi bacteria in North America. Other Borrelia species are predominately the cause of this disease in Eurasia with some distinct and various overlapping manifestations. Consequently, caution must be exercised when comparing the disease and its manifestations and treatment regimens in North America and Europe. Diagnosis of the early Lyme disease remains difficult using the currently FDA approved serological tests in the absence of a reported tick bite or of erythema migrans in many individuals, non-specific initial symptoms, and the absence of detectable anti-Borrelia antibodies in the prepatent period of infection. Furthermore, it is difficult to distinguish persistence of infection and disease versus reinfection in the endemic regions of Lyme disease by serological assays. If early infection remains untreated, spirochetes can disseminate and could affect various organs in the body with a variety of disease manifestations including arthralgias and musculoskeletal pain, neurologic symptoms and anomalies, and acrodermatitis chronicum atrophicans (ACA) in Europe. Although most patients recover after antibiotic treatment, an estimated ~10-20% patients in the United States show persistence of symptoms known as post-treatment Lyme disease syndrome (PTLDS). The causes and biomarkers of PTLDS are not well-defined; however, several contributing factors with inconsistent degree of supporting evidence have been suggested. These include antigenic debris, dysregulation of immunological response, bacterial persisters, or combination of these features. This review highlights currently employed treatment approaches describing different antimicrobials used, and vaccine candidates tried to prevent B. burgdorferi infection.

16,247 views

10 citations

ORIGINAL RESEARCH
24 September 2024
Microbiota profile in organs of the horseflies (Diptera: Tabanidae) in Northeastern China

4,109 views

2 citations

ORIGINAL RESEARCH
10 July 2024
Efficacy of sodium hypochlorite in overcoming antimicrobial resistance and eradicating biofilms in clinical pathogens from pressure ulcers
Giorgia Fabrizio, 10 more and Enea Gino Di Domenico
Efficacy of sodium hypochlorite in overcoming antimicrobial resistance and eradicating biofilms in clinical pathogens from pressure ulcers
Sodium hypochlorite (NaOCl) is an antimicrobial agent for skin wound care, recognized for its broad-spectrum antimicrobial efficacy. This study investigates the effectiveness of NaOCl against 20 bacterial isolates, including carbapenem-resistant Klebsiella pneumoniae (CRKP), multidrug-resistant Acinetobacter baumannii (MDRAB), methicillin-resistant (MRSA) and -susceptible Staphylococcus aureus (MSSA), and 5 Candida albicans isolates from pressure ulcer (PUs) patients.Antibiotic resistance was prominently observed, with CRKP and MDRAB showing resistance to fluoroquinolones and carbapenems, while MRSA displayed resistance to β-lactams and levofloxacin. MSSA exhibited a comparatively lower resistance profile. Whole-genome sequencing pinpointed specific resistance genes, with CRKP and MDRAB harboring significant numbers of antimicrobial resistance genes (ARGs) while showing fewer disinfectant resistance genes (DRGs) than MRSA and MSSA. Notably, there was a significant negative correlation between ARGs and DRGs (P=0.0468).The study also highlighted the role of genetic determinants in biofilm formation, with all isolates possessing genes related to fimbriae production and adhesion, correlating with pronounced biofilm biomass production. NaOCl demonstrated considerable antimicrobial activity against these biofilms and planktonic cells. The minimum inhibitory concentration (MIC90) for planktonic bacterial cells was 0.125 mg/mL, while the minimal biofilm eradication concentration (MBEC90) ranged between 0.225 to 0.5 mg/mL. NaOCl demonstrated an MIC90 of 0.150 mg/mL (0.125-0.175 mg/mL) against planktonic C. albicans, while the MBEC90 was 0.250 mg/mL (0.200-0.500 mg/mL).These results highlight the challenge in treating biofilm-associated infections and underscore the potential of NaOCl as a robust antimicrobial agent against difficult-to-treat biofilm infections at concentrations lower than those typically found in commercial disinfectants.

10,270 views

23 citations

Acinetobacter pittii: the emergence of a hospital-acquired pathogen analyzed from the genomic perspective
ORIGINAL RESEARCH
26 June 2024
Acinetobacter pittii: the emergence of a hospital-acquired pathogen analyzed from the genomic perspective
Elena Bello-López, 9 more and Miguel A. Cevallos
Acinetobacter pittii has increasingly been associated with several types of hospital-acquired severe infections. Genes implicated in carbapenem resistance, tigecycline resistance, or genes encoding extended spectrum cephalosporinases, such as blaADC, are commonly found in isolates implicated in these infections. A. pittii strains that are pandrug resistant have occasionally been identified. Food for human consumption, animals and plants are environmental sources of this pathogen. An alarming situation is that A. pitti has been identified as responsible for outbreaks in different regions worldwide.In this study, 384 genomes of A. pittii were analyzed, comprising sequences from clinical and non-clinical origins from 32 countries. The objective was to investigate if clinical strains possess genetic traits facilitating hospital adaptation. Results indicate significant genomic variability in terms of size and gene content among A. pittii isolates. The core genome represents a small portion (25% to 36%) of each isolate's genome, while genes associated with antibiotic resistance and virulence predominantly belong to the accessory genome.Notably, antibiotic resistance genes are encoded by a diverse array of plasmids. As the core genome between environmental and hospital isolates is the same, we can assume that hospital isolates acquired ARGs due to a high selective pressure in these settings. The strain's phylogeographic distribution indicates that there is no geographical bias in the isolate distribution; isolates from different geographic regions are dispersed throughout a core genome phylogenetic tree. A single clade may include isolates from extremely distant geographical areas. Furthermore, strains isolated from the environment or animal, or plant sources frequently share the same clade as hospital isolates.Our analysis showed that the clinical isolates do not already possess specific genes, other than antibiotic-resistant genes, to thrive in the hospital setting.

10,917 views

29 citations

ORIGINAL RESEARCH
19 June 2024
Reactivation of cytomegalovirus and bloodstream infection and its impact on early survival after allogeneic haematopoietic stem cell transplantation: a multicentre retrospective study
Jinhua Ren, 11 more and Ting Yang

3,486 views

4 citations

REVIEW
15 May 2024
Delivering CRISPR to the HIV-1 reservoirs
Theodore E. Gurrola, 4 more and Brian Wigdahl

7,507 views

10 citations

ORIGINAL RESEARCH
9 May 2024
Persistence and risk factors of occult hepatitis B virus infections among antiretroviral therapy-naïve people living with HIV in Botswana
Motswedi Anderson, 15 more and Simani Gaseitsiwe

3,892 views

8 citations